Company Profiles

driven by the PitchBook Platform

Nora Therapeutics

Description

Developer of therapeutics to address unmet needs in reproductive medicine. The company develops NT100 which is a novel treatment to reduce the risk of miscarriage in women who have a history of unexplained recurrent miscarriage.

1992

Founded

PRIVATE

Status

Later Stage VC

Latest Deal Type

$1M

Latest Deal Amount

$53.9M

Total Amount Raised

6

Investors

Description

Developer of therapeutics to address unmet needs in reproductive medicine. The company develops NT100 which is a novel treatment to reduce the risk of miscarriage in women who have a history of unexplained recurrent miscarriage.

Website:

www.noratherapeutics.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Pharmaceuticals

Other Industries

Drug Discovery
Therapeutic Devices

Primary Office

530 Lytton Avenue 2nd floor Palo Alto, CA 94301United States +1 (650) 479-5331
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Nora Therapeutics's full profile, request a free trial.

    Nora Therapeutics Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Nora Therapeutics Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Nora Therapeutics Investors (6)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Burrill & CoMerchant Banking FirmMinority000 0000000 0000
    NovoCorporate Venture CapitalMinority000 0000000 0000
    Prospect Venture PartnersVenture CapitalMinority000 0000000 0000
    Rho VenturesVenture CapitalMinority000 0000000 0000
    TEDCOVenture CapitalMinority000 0000000 0000
    Burrill & Co Merchant Banking Firm
    Novo Corporate Venture Capital
    Prospect Venture Partners Venture Capital
    Rho Ventures Venture Capital
    TEDCO Venture Capital

    Nora Therapeutics Executive Team (5)

    NameTitleBoard
    Seat
    Contact
    Info
    Jeffrey Tong Ph.DPresident, Board Member & Chief Executive Officer
    Chris McClainExecutive Director, Business Affairs & Co-Founder
    Darryl Carter MDOwner, Co-Founder & Vice President, Research
    Sandra ShpilbergVice President, Strategic Marketing & Commercial Planning
    Mark JoingVice President, Clinical Operations & Project Management
    Jeffrey Tong Ph.D President, Board Member & Chief Executive Officer
    Chris McClain Executive Director, Business Affairs & Co-Founder
    Darryl Carter MD Owner, Co-Founder & Vice President, Research
    Sandra Shpilberg Vice President, Strategic Marketing & Commercial Planning
    Mark Joing Vice President, Clinical Operations & Project Management

    Nora Therapeutics Board Members (9)

    NameRepresentingRoleSinceContact
    Info
    Anupam Dalal MDSelfBoard Member000 0000
    Chen-Ming Yu MDVivo CapitalManaging Partner000 0000
    David Schnell MDProspect Venture PartnersCo-Founder, Partner & Managing Director000 0000
    Dennis Fenton Ph.DSelfBoard Member000 0000
    Donald Hayden Jr.Prospect Venture PartnersSenior Advisor000 0000
    Anupam Dalal MD Board Member Self
    Chen-Ming Yu MD Managing Partner Vivo Capital
    David Schnell MD Co-Founder, Partner & Managing Director Prospect Venture Partners
    Dennis Fenton Ph.D Board Member Self
    Donald Hayden Jr. Senior Advisor Prospect Venture Partners
    Request full access to PitchBook